Pescarmona E, Pignoloni P, Mauro F R, Cerretti R, Anselmo A P, Mandelli F, Baroni C D
Laboratorio di Istopatologia c/o Ematologia, Rome, Italy.
Virchows Arch. 2000 Aug;437(2):129-32. doi: 10.1007/s004280000214.
We report the immunohistological, molecular and clinical findings in four patients affected by B-cell chronic lymphocytic leukaemia (CLL) who developed "Richter's syndrome with Hodgkin's disease (HD) features" or "CLL with Hodgkin's transformation", all characterised by the presence of typical Hodgkin/Reed-Sternberg (H/RS) cells in lymph node biopsies. In three cases the nodal involvement by CLL was demonstrated both by the presence of a predominant background of CD5/CD19/CD23+ small lymphocytes and an IgH monoclonal rearrangement revealed by PCR analysis. Conversely, in the remaining case there was neither immunohistological nor molecular evidence of lymph node involvement by CLL. In all four cases H/RS cells were Epstein-Barr virus (EBV) latent membrane protein (LMP-1) positive. These findings suggest that the presence of H/RS cells in the first three patients, who had CLL/HD nodal involvement, might be related to transformation or clonal evolution of CLL cells in H/RS cells, which is in keeping with use of the term "CLL with Hodgkin's transformation". In the fourth case a de novo HD may be postulated, representing a second malignancy presumably not clonally related to CLL. In all cases a key pathogenetic role of EBV is suggested by the expression of LMP-1 in H/RS cells. Our findings indicate that the presence of typical H/RS cells in lymph node biopsies in CLL patients may reflect a heterogeneous pathogenetic background. The different clinico-pathologic settings should be taken into consideration because of their possible implications for patients' treatment and prognosis.
我们报告了4例B细胞慢性淋巴细胞白血病(CLL)患者的免疫组织学、分子学及临床研究结果,这些患者均发展为“具有霍奇金淋巴瘤(HD)特征的里氏综合征”或“CLL伴霍奇金转化”,其淋巴结活检均有典型的霍奇金/里德-斯特恩伯格(H/RS)细胞。3例中,CLL的淋巴结受累表现为CD5/CD19/CD23⁺小淋巴细胞为主的背景,且PCR分析显示有IgH单克隆重排。相反,在其余1例中,既无免疫组织学证据也无分子学证据支持CLL累及淋巴结。4例中H/RS细胞均为EB病毒(EBV)潜伏膜蛋白(LMP-1)阳性。这些发现提示,前3例有CLL/HD淋巴结受累患者中H/RS细胞的存在,可能与CLL细胞向H/RS细胞的转化或克隆进化有关,这与“CLL伴霍奇金转化”这一术语的使用相符。在第4例中,可能为新发HD,代表一种可能与CLL无克隆相关性的第二种恶性肿瘤。在所有病例中,H/RS细胞中LMP-1的表达提示EBV起关键致病作用。我们的发现表明,CLL患者淋巴结活检中典型H/RS细胞的存在可能反映了异质性的致病背景。由于其可能对患者治疗及预后产生影响,不同的临床病理情况应予以考虑。